CLINICAL TRIALS PROFILE FOR VEKLURY
✉ Email this page to a colleague
All Clinical Trials for VEKLURY
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT04784559 ↗ | Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection | Recruiting | PharmaMar | Phase 3 | 2021-06-04 | Treatment of patients hospitalised for management of moderate COVID-19 infection |
NCT04832880 ↗ | Factorial Randomized Trial of Rendesivir and Baricitinib Plus Dexamethasone for COVID-19 (the AMMURAVID Trial) | Not yet recruiting | ASST Fatebenefratelli Sacco | Phase 3 | 2021-04-06 | Background: In the current worldwide medical emergency, a rapid identification of effective therapeutic strategy is crucial. So far, therapy with dexamethasone, remdesivir and baricitinib have been associated with evidence of impact on the clinical impact on COVID-19, but the effect of baricitinib and remdesivir in combination with dexamethasone. The AAMMURAVID trial is endorced and supported by the Italian Regulatory agency (AIFA-Agenzia Italiana del Farmaco) |
NCT04853901 ↗ | Remdesivir Efficacy In Management Of COVID-19 Patients | Completed | Ain Shams University | Phase 3 | 2020-07-27 | The study is open label randomized interventional phase 3 clinical trial. Patients with confirmed Covid-19 cases who was hospitalized in Two university isolation hospitals (Ain Shams University and Assiut University ) assigned hospitals for isolation. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for VEKLURY
Condition Name
Clinical Trial Locations for VEKLURY
Clinical Trial Progress for VEKLURY
Clinical Trial Phase
Clinical Trial Sponsors for VEKLURY
Sponsor Name